Ezra

Ezra is focused on early cancer detection through the use of full-body MRI scans. Given that early detection significantly increases survival rates, Ezra's annual Full Body Scans aim to identify cancer signs early, potentially preventing late-stage diagnoses. The company has developed MRI and low-dose CT scanning protocols to detect potential cancers in up to 13 organs, offering a non-invasive alternative to traditional biopsies. Led by CEO Emi Gal, who has extensive experience in technology and company scaling, Ezra plans to scan one million people annually by 2030. The leadership team includes experts in MRI innovation, emergency medicine, commercial strategy, and regulatory compliance. Supported by top medical advisors, including researchers from prestigious institutions, Ezra continues to enhance its technology to make cancer screenings more accessible and effective.